Activation of programmed (apoptotic) cell death for the treatment of prostate cancer

Adv Pharmacol. 1996:35:281-306. doi: 10.1016/s1054-3589(08)60278-1.
No abstract available

Publication types

  • Review

MeSH terms

  • Apoptosis / drug effects*
  • Apoptosis / genetics
  • Gene Expression
  • Humans
  • Male
  • Neoplasm Metastasis
  • Prodrugs
  • Prostatic Neoplasms / pathology*
  • Prostatic Neoplasms / therapy
  • Sesquiterpenes / adverse effects
  • Sesquiterpenes / pharmacology
  • Sesquiterpenes / therapeutic use
  • Thapsigargin / adverse effects
  • Thapsigargin / pharmacology
  • Thapsigargin / therapeutic use

Substances

  • Prodrugs
  • Sesquiterpenes
  • Thapsigargin